ORCID as entered in ROS

Select Publications
2020, 'Response to Chapman and Daube', Drug and Alcohol Review, 39, pp. 422 - 423, http://dx.doi.org/10.1111/dar.13066
,2020, 'Does the gateway theory justify a ban on nicotine vaping in Australia?', International Journal of Drug Policy, 78, http://dx.doi.org/10.1016/j.drugpo.2020.102712
,2020, 'Ensuring access to safe, effective, and affordable cannabis-based medicines', British Journal of Clinical Pharmacology, 86, pp. 630 - 634, http://dx.doi.org/10.1111/bcp.14242
,2020, 'A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations', Addiction, 115, pp. 462 - 472, http://dx.doi.org/10.1111/add.14852
,2020, 'Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102698
,2020, 'Initial indicators of the public health impacts of non-medical cannabis legalization in Canada', Eclinicalmedicine, 20, http://dx.doi.org/10.1016/j.eclinm.2020.100294
,2020, 'Cannabinoids for the treatment of mental disorders – Author's reply', Lancet Psychiatry, 7, pp. 127 - 128, http://dx.doi.org/10.1016/S2215-0366(19)30526-7
,2020, 'Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004))', Neuron, 105, pp. 201, http://dx.doi.org/10.1016/j.neuron.2019.12.019
,2020, 'Miscommunication about the causes of the US outbreak of lung diseases in vapers by public health authorities and the media', Drug and Alcohol Review, 39, pp. 3 - 6, http://dx.doi.org/10.1111/dar.13024
,2020, 'Road safety risks of cannabis use: Sales need to fund research', American Journal of Public Health, 110, pp. 265 - 266, http://dx.doi.org/10.2105/AJPH.2019.305529
,2020, 'The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years', Addiction, 115, pp. 145 - 155, http://dx.doi.org/10.1111/add.14761
,2020, 'Book Forum', Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 82, pp. 101268 - 101268, http://dx.doi.org/10.1016/j.shpsc.2020.101268
,2020, 'The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand', PUBLIC HEALTH IN PRACTICE, 1, http://dx.doi.org/10.1016/j.puhip.2020.100046
,2019, 'Alcohol consumption and consequences in adolescents in 68 low and middle-income countries – a multi-country comparison of risks by sex', Drug and Alcohol Dependence, 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.022
,2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine United States, 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009
,2019, 'Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis', Lancet Psychiatry, 6, pp. 995 - 1010, http://dx.doi.org/10.1016/S2215-0366(19)30401-8
,2019, 'Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids', Drug and Alcohol Dependence, 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.035
,2019, 'What Have Been the Public Health Impacts of Cannabis Legalisation in the USA? A Review of Evidence on Adverse and Beneficial Effects', Current Addiction Reports, 6, pp. 418 - 428, http://dx.doi.org/10.1007/s40429-019-00291-x
,2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', Lancet, 394, pp. 1668 - 1684, http://dx.doi.org/10.1016/S0140-6736(19)32231-7
,2019, 'Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada', International Journal of Drug Policy, 73, pp. 96 - 99, http://dx.doi.org/10.1016/j.drugpo.2019.06.020
,2019, 'Public health implications of legalising the production and sale of cannabis for medicinal and recreational use', Lancet, 394, pp. 1580 - 1590, http://dx.doi.org/10.1016/S0140-6736(19)31789-1
,2019, 'Strategies to reduce drug-related harm: responding to the evidence base', Lancet, 394, pp. 1490 - 1493, http://dx.doi.org/10.1016/S0140-6736(19)32232-9
,2019, 'Social, demographic, and economic correlates of food and chemical consumption measured by wastewater-based epidemiology', Proceedings of the National Academy of Sciences of the United States of America, 116, pp. 21864 - 21873, http://dx.doi.org/10.1073/pnas.1910242116
,2019, 'HOW TO CHANGE YOUR MIND: THE NEW SCIENCE OF PSYCHEDELICS', ADDICTION, 114, pp. 1892 - 1893, http://dx.doi.org/10.1111/add.14702
,2019, 'Predicting vaping uptake, vaping frequency and ongoing vaping among daily smokers using longitudinal data from the International Tobacco Control (ITC) Four Country Surveys', Addiction, 114, pp. 61 - 70, http://dx.doi.org/10.1111/add.14537
,2019, 'Correlates of electronic cigarette use in the general population and among smokers in Australia – Findings from a nationally representative survey', Addictive Behaviors, 95, pp. 6 - 10, http://dx.doi.org/10.1016/j.addbeh.2019.02.012
,2019, 'The Age of Addiction: How Bad Habits Became Big Business', ADDICTION, 114, pp. 2087 - 2087, http://dx.doi.org/10.1111/add.14751
,2019, 'Capacity, control and responsibility in Parkinson's disease patients with impulse control disorders: Views of neurological and psychiatric experts', International Journal of Law and Psychiatry, 65, http://dx.doi.org/10.1016/j.ijlp.2018.04.003
,2019, 'Cannabinoids for the treatment of spasticity', Developmental Medicine and Child Neurology, 61, pp. 631 - 638, http://dx.doi.org/10.1111/dmcn.14165
,2019, 'Traffic fatalities within US states that have legalized recreational cannabis sales and their neighbours', Addiction, 114, pp. 847 - 856, http://dx.doi.org/10.1111/add.14536
,2019, 'Concerns and help-seeking among patients using opioids for management of chronic noncancer pain', Pain Medicine United States, 20, pp. 758 - 769, http://dx.doi.org/10.1093/pm/pny078
,2019, 'A Neuroethics Framework for the Australian Brain Initiative', Neuron, 101, pp. 365 - 369, http://dx.doi.org/10.1016/j.neuron.2019.01.004
,2019, 'A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA', Lancet Public Health, 4, pp. e77 - e78, http://dx.doi.org/10.1016/S2468-2667(19)30001-5
,2019, 'Cannabis use and mental health: risks and benefits', European Archives of Psychiatry and Clinical Neuroscience, 269, http://dx.doi.org/10.1007/s00406-019-00986-2
,2019, 'Finding acceptable ways to fund research on e-cigarettes', Addiction, 114, pp. 375 - 376, http://dx.doi.org/10.1111/add.14465
,2019, 'Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates', Drug and Alcohol Review, 38, pp. 151 - 158, http://dx.doi.org/10.1111/dar.12893
,2019, 'A National Wastewater Monitoring Program for a better understanding of public health: A case study using the Australian Census', Environment International, 122, pp. 400 - 411, http://dx.doi.org/10.1016/j.envint.2018.12.003
,2019, 'Commentary on Burgard et al. (2019): Wastewater based estimates of the size of illicit markets for psychoactive drugs', Addiction, 114, pp. 1591 - 1592, http://dx.doi.org/10.1111/add.14716
,2019, 'Longitudinal patterns of amphetamine use from adolescence to adulthood: A latent class analysis of a 20-year prospective study of Australians', Drug and Alcohol Dependence, 194, pp. 121 - 127, http://dx.doi.org/10.1016/j.drugalcdep.2018.08.042
,2019, 'The Indian Hemp Drugs Commission 1893–1894', Addiction, 114, pp. 1679 - 1682, http://dx.doi.org/10.1111/add.14640
,2018, 'Has the Legalisation of Medical and Recreational Cannabis Use in the USA Affected the Prevalence of Cannabis Use and Cannabis Use Disorders?', Current Addiction Reports, 5, pp. 403 - 417, http://dx.doi.org/10.1007/s40429-018-0224-9
,2018, 'The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016', Lancet Psychiatry, 5, pp. 987 - 1012, http://dx.doi.org/10.1016/S2215-0366(18)30337-7
,2018, 'Non-medical prescription stimulant use to improve academic performance among Australian university students: Prevalence and correlates of use', BMC Public Health, 18, http://dx.doi.org/10.1186/s12889-018-6212-0
,2018, 'Can automated content analysis be used to assess and improve the use of evidence in mental health policy? A systematic review 16 Studies in Human Society 1605 Policy and Administration', Systematic Reviews, 7, http://dx.doi.org/10.1186/s13643-018-0853-z
,2018, 'Adverse adult consequences of different alcohol use patterns in adolescence: an integrative analysis of data to age 30 years from four Australasian cohorts', Addiction, 113, pp. 1811 - 1825, http://dx.doi.org/10.1111/add.14263
,2018, 'Global statistics on alcohol, tobacco and illicit drug use: 2017 status report', Addiction, 113, pp. 1905 - 1926, http://dx.doi.org/10.1111/add.14234
,2018, 'The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial', Addiction, 114, pp. 923 - 933, http://dx.doi.org/10.1111/add.14541
,2018, 'Minimizing the adverse public health effects of cannabis legalization', CMAJ, 190, pp. E1031 - E1032, http://dx.doi.org/10.1503/cmaj.181035
,2018, 'What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review', International Review of Psychiatry, 30, pp. 91 - 106, http://dx.doi.org/10.1080/09540261.2018.1509842
,2018, 'Amphetamine use in the fourth decade of life: Social profiles from a population-based Australian cohort', Drug and Alcohol Review, 37, pp. 743 - 751, http://dx.doi.org/10.1111/dar.12840
,